A detailed history of Beacon Investment Advisory Services, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Beacon Investment Advisory Services, Inc. holds 7,000 shares of AZN stock, worth $544,250. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,000
Previous 7,000 -0.0%
Holding current value
$544,250
Previous $471,000 0.64%
% of portfolio
0.02%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 21, 2022

SELL
$59.26 - $71.14 $9,363 - $11,240
-158 Reduced 2.21%
7,000 $462,000
Q1 2022

May 12, 2022

SELL
$55.72 - $67.12 $6,129 - $7,383
-110 Reduced 1.51%
7,158 $474,000
Q4 2021

Feb 04, 2022

BUY
$54.02 - $63.83 $5,942 - $7,021
110 Added 1.54%
7,268 $423,000
Q3 2021

Nov 09, 2021

SELL
$55.56 - $60.79 $4,444 - $4,863
-80 Reduced 1.11%
7,158 $430,000
Q2 2021

Aug 02, 2021

SELL
$48.42 - $60.18 $12,395 - $15,406
-256 Reduced 3.42%
7,238 $434,000
Q1 2021

May 21, 2021

SELL
$47.16 - $54.44 $45,981 - $53,079
-975 Reduced 11.51%
7,494 $373,000
Q4 2020

Feb 08, 2021

SELL
$48.52 - $58.02 $137,554 - $164,486
-2,835 Reduced 25.08%
8,469 $423,000
Q3 2020

Oct 29, 2020

BUY
$53.07 - $61.1 $29,453 - $33,910
555 Added 5.16%
11,304 $619,000
Q2 2020

Jul 28, 2020

BUY
$43.1 - $55.31 $146,712 - $188,275
3,404 Added 46.34%
10,749 $569,000
Q4 2019

Jan 31, 2020

BUY
$42.46 - $50.46 $14,648 - $17,408
345 Added 4.93%
7,345 $366,000
Q2 2019

Aug 07, 2019

SELL
$37.28 - $41.68 $372,800 - $416,800
-10,000 Reduced 58.82%
7,000 $289,000
Q1 2019

May 15, 2019

SELL
$35.49 - $43.02 $17,390 - $21,079
-490 Reduced 2.8%
17,000 $687,000
Q4 2018

Feb 08, 2019

SELL
$36.86 - $41.49 $1,511 - $1,701
-41 Reduced 0.23%
17,490 $664,000
Q3 2018

Nov 09, 2018

SELL
$34.76 - $39.72 $241,547 - $276,014
-6,949 Reduced 28.39%
17,531 $694,000
Q2 2018

Aug 09, 2018

SELL
$34.55 - $37.05 $9,259 - $9,929
-268 Reduced 1.08%
24,480 $859,000
Q1 2018

Apr 26, 2018

BUY
$32.97 - $36.63 $112,098 - $124,542
3,400 Added 15.93%
24,748 $865,000
Q4 2017

Feb 02, 2018

SELL
$32.09 - $34.78 $221,870 - $240,468
-6,914 Reduced 24.46%
21,348 $741,000
Q3 2017

Nov 14, 2017

BUY
$28.96 - $34.0 $818,467 - $960,908
28,262
28,262 $957,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $241B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Beacon Investment Advisory Services, Inc. Portfolio

Follow Beacon Investment Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Investment Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beacon Investment Advisory Services, Inc. with notifications on news.